FGF21 Regulates Sweet and Alcohol Preference

Slides:



Advertisements
Similar presentations
Mitoconfusion: Noncanonical Functioning of Dynamism Factors in Static Mitochondria of the Heart Moshi Song, Gerald W. Dorn Cell Metabolism Volume 21, Issue.
Advertisements

Volume 10, Issue 4, Pages (October 2009)
Volume 2, Issue 4, Pages (October 2005)
Jochen G. Schneider, Joseph H. Nadeau  Cell Metabolism 
Volume 25, Issue 22, Pages (November 2015)
Volume 15, Issue 1, Pages (January 2012)
Volume 79, Issue 3, Pages (August 2013)
Volume 18, Issue 3, Pages (September 2013)
Volume 18, Issue 7, Pages (February 2017)
Volume 24, Issue 3, Pages (September 2016)
Volume 20, Issue 2, Pages (August 2014)
Oxytocin Mobilizes Midbrain Dopamine toward Sociality
Volume 23, Issue 3, Pages (March 2016)
Volume 13, Issue 8, Pages (November 2015)
FGF21 Is an Exocrine Pancreas Secretagogue
Volume 17, Issue 5, Pages (May 2013)
Volume 15, Issue 2, Pages (February 2012)
Volume 12, Issue 4, Pages (October 2010)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 4, Issue 3, Pages (September 2006)
Treating Obesity? It's in the Bag!
Volume 7, Issue 3, Pages (March 2008)
Shedding “UV” Light on Endogenous Opioid Dependence
Jianrong Tang, John A. Dani  Neuron 
Volume 18, Issue 6, Pages (December 2013)
Maribel Rios  Trends in Neurosciences 
Volume 23, Issue 2, Pages (February 2016)
Volume 18, Issue 5, Pages (November 2013)
Volume 25, Issue 6, Pages e8 (June 2017)
Volume 19, Issue 2, Pages (February 2014)
Volume 2, Issue 6, Pages (December 2005)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 17, Issue 5, Pages (May 2013)
Diet-Induced Obese Mice Retain Endogenous Leptin Action
Volume 22, Issue 4, Pages (October 2015)
μ-Opioid Receptor and CREB Activation Are Required for Nicotine Reward
Volume 90, Issue 3, Pages (May 2016)
Critical Role for Hypothalamic mTOR Activity in Energy Balance
Volume 9, Issue 5, Pages (May 2009)
Volume 16, Issue 6, Pages (August 2016)
Volume 10, Issue 2, Pages (August 2009)
Volume 20, Issue 1, Pages (July 2014)
Volume 21, Issue 5, Pages (May 2015)
Volume 22, Issue 1, Pages (July 2015)
Volume 25, Issue 4, Pages e4 (April 2017)
Volume 1, Issue 4, Pages (April 2005)
Volume 15, Issue 5, Pages (May 2012)
Volume 6, Issue 5, Pages (November 2007)
Volume 8, Issue 2, Pages (August 2008)
Rapid versus Delayed Stimulation of Feeding by the Endogenously Released AgRP Neuron Mediators GABA, NPY, and AgRP  Michael J. Krashes, Bhavik P. Shah,
Volume 9, Issue 6, Pages (June 2009)
Volume 18, Issue 3, Pages (September 2013)
Induction of Leptin Resistance by Activation of cAMP-Epac Signaling
Dopamine Scales Performance in the Absence of New Learning
Volume 66, Issue 6, Pages (June 2010)
Volume 7, Issue 6, Pages (June 2008)
Volume 22, Issue 4, Pages (October 2015)
Volume 3, Issue 3, Pages (March 2006)
PPARγ in Vagal Neurons Regulates High-Fat Diet Induced Thermogenesis
Volume 20, Issue 4, Pages (October 2014)
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 1, Issue 6, Pages (June 2005)
Joan Goulley, Ulf Dahl, Nathalie Baeza, Yuji Mishina, Helena Edlund 
Volume 69, Issue 2, Pages (January 2011)
Volume 30, Issue 3, Pages (May 2001)
Volume 24, Issue 1, Pages 7-8 (July 2016)
Volume 20, Issue 4, Pages (October 2014)
The GCN2 eIF2α Kinase Regulates Fatty-Acid Homeostasis in the Liver during Deprivation of an Essential Amino Acid  Feifan Guo, Douglas R. Cavener  Cell.
Volume 16, Issue 3, Pages (September 2012)
Presentation transcript:

FGF21 Regulates Sweet and Alcohol Preference Saswata Talukdar, Bryn M. Owen, Parkyong Song, Genaro Hernandez, Yuan Zhang, Yingjiang Zhou, William T. Scott, Bhavna Paratala, Tod Turner, Andrew Smith, Barbara Bernardo, Christian P. Müller, Hao Tang, David J. Mangelsdorf, Bryan Goodwin, Steven A. Kliewer  Cell Metabolism  Volume 23, Issue 2, Pages 344-349 (February 2016) DOI: 10.1016/j.cmet.2015.12.008 Copyright © 2016 Elsevier Inc. Terms and Conditions

Cell Metabolism 2016 23, 344-349DOI: (10.1016/j.cmet.2015.12.008) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 FGF21 Decreases Sweet Preference Ratio in Mice by Acting on the CNS (A) Two-bottle preference assay in wild-type (WT) and Tg(Fgf21) mice administered water versus 3% sucrose. Representative 24 hr data from day 2 after initiating the assay are shown as the sucrose preference ratio (sucrose intake volume/total fluid intake volume). n = 10–11/group. (B) Two-bottle preference assay in WT and Tg(Fgf21) mice administered water versus 0.2% saccharin. Representative 24 hr data from day 2 after initiating the assay are shown. n = 10–11/group. (C) Two-bottle preference assay with water versus 0.2% saccharin for Klbfl/fl and KlbCamk2a mice administered either FGF21 (1 mg/kg/day) or vehicle. Representative 24 hr data from day 3 after initiating the assay are shown. n = 6–9/group. (D) Two-bottle preference assay with water versus 2 mg/dl quinine for Klbfl/fl and KlbCamk2a mice administered either FGF21 (1 mg/kg/day) or vehicle. n = 4/group. Values are means ± SEM. ∗∗p < 0.01, ∗∗∗p < 0.001, ###p < 0.001 by Student’s t test. See also Figure S1 and Tables S1 and S2. Cell Metabolism 2016 23, 344-349DOI: (10.1016/j.cmet.2015.12.008) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 2 A Stable FGF21 Analog Decreases Saccharin Preference in Mice and Monkeys (A) Two-bottle preference assay with 0.1% saccharin in diet-induced obese mice administered either PF-05231023 (10 mg/kg) or vehicle on days 0, 3, 7, and 10. Data are shown as the mean ± SEM; n = 8/group. ∗∗p < 0.01, ∗∗∗p < 0.001 versus vehicle group. (B) Two-bottle preference assay with 0.2% saccharin in obese cynomolgus monkeys administered either PF-05231023 (n = 8; 10 mg/kg) or vehicle (n = 7) on days 1, 4, and 7. Data are presented as mean percentage change in saccharin water intake ± SEM for vehicle-treated (closed blue circles) and PF-05231023-treated (open red circles) monkeys. Solid lines are locally weighted scatterplot smoothing fits to the means of percent change. Mixed effect modeling fitted to these longitudinal data using R, version 3.1.2 (Pinheiro et al., 2013), showed a significant difference (p = 0.003) between groups. Number of days after first treatment, treatment type, and the interaction term between treatment groups and time were specified as fixed effects and monkey labels as a random effect. Cell Metabolism 2016 23, 344-349DOI: (10.1016/j.cmet.2015.12.008) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 3 FGF21 Affects Dopamine Signaling (A) β-Klotho (Klb) mRNA levels in the suprachiasmatic nucleus/paraventricular nucleus (SCN/PVN) region of the hypothalamus, ventral tegmental area (VTA), nucleus accumbens (NAc), medial prefrontal cortex (PFC), and caudate putamen of Klb+/− and Klb−/− mice (n = 6/group). Ct values are shown in the bars. ND, not detected. (B) Concentrations of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and 3-methoxytyramine (3-MT) in the NAc of mice administered either vehicle or FGF21 for 2 weeks by osmotic minipump (n = 12/group). (C and D) mRNA levels of dopamine transporter (Slc6a3) or (D) catechol-O-methyl transferase (Comt) in VTA, NAc, and caudate putamen of mice administered either vehicle or FGF21 for 2 weeks by osmotic minipump (n = 7–8/group). Ct values are shown. Values are means ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 versus control group by Student’s t test. See also Figure S2. Cell Metabolism 2016 23, 344-349DOI: (10.1016/j.cmet.2015.12.008) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 4 FGF21 Decreases Alcohol Preference (A) Ethanol preference ratio in wild-type (WT) and Tg(Fgf21) mice at the indicated ethanol concentrations (n = 9/group). (B) Plasma ethanol concentrations in groups of WT and Tg(Fgf21) mice 1 or 3 hr after i.p. injection of ethanol (4 g/kg) (n = 4–5/group). Values are means ± SEM. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 versus control group by Student’s t test. See also Table S3. Cell Metabolism 2016 23, 344-349DOI: (10.1016/j.cmet.2015.12.008) Copyright © 2016 Elsevier Inc. Terms and Conditions